Latest news

Carevive has won the first Pfizer Patient Reported Outcomes Challenge

Debiopharm invests in DTx leader Voluntis

BC Platforms Partners with CO-CONNECT Consortium to accelerate COVID-19 research

Immunexpress’ rapid test for sepsis launched in Europe on Biocartis’ Idylla platform

Debiopharm co-leads an investment round of €10 million in Oncomfort

Debiopharm invests in NucleAI– using AI to develop digital pathology biomarkers

Debiopharm and Ipsen Win the 2020 ASAP Alliance Excellence Awards

Immunexpress awarded funding to develop their COVID-19 patient triage test SeptiCyte® RAPID

Acquisition of Kaiku Health by the swedish company Elekta